Mankind Pharma, operating in the Pharmaceuticals sector and classified as a Largecap on the BSE, currently has its share price at ₹2582.65. The stock has experienced fluctuations today ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Sol-Gel Technologies (SLGL) entered into a product purchase agreement with a subsidiary of Mayne Pharma Group (MAYNF) for the sale and exclusive license of the U.S. rights to EPSOLAY and TWYNEO.

Alembic Pharmaceuticals Limited on April 17, 2025, informed that it has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA ...

Natco Pharma, operating in the Pharmaceuticals sector and classified as a Smallcap on the BSE, currently has its share price at ₹826.85. The stock has experienced fluctuations today, with a low ...

Conduit Pharmaceuticals (CDT) announced key leadership changes to support the company’s next phase of growth and execution. Dr. Andrew Regan, the founder and initial financial backer of Conduit ...

Mankind Pharma Ltd., incorporated in the year 1991, is a Small Cap company (having a market cap of Rs 1,06,511.27 Crore) operating in Pharmaceuticals sector. Mankind Pharma Ltd. key Products/Revenue ...

The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.

The investment objective of the scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies engaged in Pharma and Healthcare.